pyridoxine has been researched along with Macular Degeneration in 2 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christen, WG | 1 |
| Glynn, RJ | 1 |
| Chew, EY | 1 |
| Albert, CM | 1 |
| Manson, JE | 1 |
| Lipkan, GN | 1 |
| Umovist, NM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)[NCT00000541] | Phase 2 | 0 participants | Interventional | 1993-05-31 | Completed | ||
| [NCT00000161] | Phase 3 | 0 participants | Interventional | 1993-08-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pyridoxine and Macular Degeneration
| Article | Year |
|---|---|
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Endpoint Deter | 2009 |
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Endpoint Deter | 2009 |
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Endpoint Deter | 2009 |
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Endpoint Deter | 2009 |
1 other study available for pyridoxine and Macular Degeneration
| Article | Year |
|---|---|
[Effect of vitamin B 6 therapy on blood coagulation indicators in patients with arteriosclerotic dystrophy of macula lutea].
Topics: Adult; Arteriosclerosis; Blood Coagulation; Female; Humans; Macular Degeneration; Male; Middle Aged; | 1975 |